Return to News

COSMIC News

logo

Do you have data for COSMIC?

30 Jan 2018

COSMIC welcomes researchers submitting data to us directly either pre- or post-publication, the following article outlines how to do this. 

Are your findings published? Firstly congratulations! In that case, we probably already know about your paper. As a matter of course we continually search the literature for papers relevant to both our currently curated genes and genes that are soon to be curated, so chances are your paper is already on the 'to do' list! However, you are more than welcome to drop us a line and check that we have seen your paper. Contact us on cosmic@sanger.ac.uk.

If you are pre-publication, we are also happy to accept your data (and generate a COSP identifier as a proof of data submission to COSMIC that you can communicate to a journal if required).  Although at this point we would not be able to display your data on the website or in the download files until it can be linked to a peer-reviewed publication. Although we do periodically check, we also ask that you let us know as soon as your paper is published so that we can include your data in the next update of COSMIC. 

What form should your data take? In order to make the curation process as efficient and accurate as possible, we have some guidelines about the format and level of detail that we require. By following these guidelines authors will contribute to the quick and efficient dissemination of their research results via COSMIC.

Samples:

  • Data in COSMIC is curated per sample. Thus mutation or clinical data can only be entered if it is in reference to a sample. The minimum requirement for a sample to be included is the full mutation details at the nucleotide and ideally protein level (see below).
  • Samples reported in an earlier publication will be excluded to avoid duplication. Indicating that a sample is a duplicate is very helpful.
  • Papers reporting samples with more than one mutation (from one or more genes) please specify which mutations occur together in a sample.

Reference Sequences:

  • Please state which reference sequence and version was used to describe the mutations (e.g. NM_0060165.3 or ENST00000215919). This makes mapping mutations to the COSMIC reference sequence much easier, and for some mutations is absolutely essential.  

Mutations:

  • Ideally mutations would be described both at the nucleotide and amino acid level. Please note we can not accept mutations without genomic nucleotide coordinates. 

  • COSMIC mutation syntax is based on the HGVS syntax, it is useful if authors also use this nomenclature. For insertion mutations it is helpful if they are described as e.g. c.1118_1119insA rather than c.1118insA which can be ambiguous. If the protein result e.g. p.N373s*6 is also provided, the position can be confirmed. 

Suggested presentation of results:

data submission

The table above shows a suggested layout which makes your results easier to incorporate into COSMIC. Clinical fields can be filled in if the data is available and additional columns can be added for further information e.g. smoking status, drug response etc. We have a template of this table available which can be adapted as necessary, alternatively we can also accept your VCF formatted files that you may already have. If you have any queries or  would like to submit data, please get in touch at cosmic@sanger.ac.uk.

About

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the most comprehensive resource for exploring the impact of somatic mutations in human cancer. Here on our news page we aim to give you an insight into what we are doing and why. We will keep you updated with new developments and release information as well as any events we are hosting.

Tags

release

workshop

website

curation

COSMIC-3D

vacancies

downloads

user experience

data submission

website update

Cancer Gene Census

mutation ID

Hallmarks of Cancer

GRCh37

drug resistance

GRCh38

video

tutorial

birthday

International Women's Day

literature

mutational signatures

Mesothelioma

conference

AACR

gene

Bile duct cancer

cholangiocarcinoma

Europe PMC

Service announcement

blog

survey

updates

v90

search

cosv

updated

CDS

Fasta

cDNA

disease focus

world cancer day

new product

cmc

DIAS

Actionability

COSMIC

webinar

introduction to cosmic

mutations

celebrating success

Oncology

oncology trials

precision medicine

clinical trials

precision oncology

cancer

genomics

immuno oncology

breast cancer

cosmic v95

bioinformatics

cancermutationcensus

COSMICv95

Lung Cancer

Glioblastoma

testicular cancer

cancer prevention

biomarkers

Cancer Research

tumour microenvironment

copy number variants

ageing

genes

genome

clones

smoking

Clonal haematopoesis

tumour

inherited

disease

individuals

risk

variants

leukaemia

Myelodysplastic syndrome

lymphoma

haematological cancers

Myeoloproliferative neoplasms

myeloma

haematological

somatic mutations

blood cancers

blood cancer

NRAS

acral lentiginous melanoma

BRAF

melanoma

driver gene

skin cancer

uv light

Mexico

chromosome

acral melanoma

breed predisposition

genetics

PIK3CA

driver genes

canine cancer

data ecosystem

database

canine

tumour board

barrett's oesophagus

oesophageal cancer

upper gi

gene panel

cell lines project

Wellcome Sanger Institute

sanger

uv radiation

uv nail lamp

SBS18

reactive oxygen species

DNA damage

uv damage

sebaceous gland carcinoma

Kaposi cell carcinoma

Lynch syndorme

carcinoma

cancerresearch

Merkel cell carcinoma

Muir-torres syndrome

MLH1

sanger institute

Mike Stratton

cancer genome project

BRCA2

mutographs

resistance mutations

IWD24

Women in STEM

IT

computational biology

STEM career

computer science